Skip to main content
HANGZHOU AGS MEDTECH CO.,LTD logo

HANGZHOU AGS MEDTECH CO.,LTD — Investor Relations & Filings

Ticker · 688581 ISIN · CNE100005ZF0 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 393 across all filing types
Latest filing 2023-09-07 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 688581

About HANGZHOU AGS MEDTECH CO.,LTD

http://www.bioags.com/en/index.aspx

Hangzhou AGS MedTech Co., Ltd. specializes in the research, development, and manufacturing of minimally invasive medical instruments, primarily focusing on endoscopic accessories. The product portfolio encompasses a comprehensive range of disposable devices for gastrointestinal and respiratory interventions, including biopsy forceps, hemoclips, injection needles, polypectomy snares, and guide wires. The company integrates advanced manufacturing processes with rigorous quality management systems, adhering to international standards such as ISO 13485, CE, and FDA. By providing high-precision diagnostic and therapeutic tools, the organization supports clinical procedures in gastroenterology and pulmonology. Its technical expertise facilitates the delivery of reliable solutions aimed at improving procedural outcomes and patient safety in global healthcare markets.

Recent filings

Filing Released Lang Actions
安杰思第二届董事会第七次会议决议公告
Board/Management Information Classification · 95% confidence The document is a board meeting resolution announcement from Hangzhou Anjiesi Medical Technology Co., Ltd. It details the approval of a restricted stock incentive plan and the granting of restricted shares to incentive recipients. The document includes meeting details, voting results, and references to related announcements. It is not a full financial report, audit, or earnings release, nor is it a regulatory filing or proxy solicitation. The content focuses on board decisions and management actions regarding stock incentives, which fits the category of Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication, so it is not RPA. Therefore, the classification is MANG with high confidence.
2023-09-07 Chinese
安杰思第二届监事会第五次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of a supervisory board meeting resolution regarding the initial grant of restricted stock under a 2023 stock incentive plan. It includes details about the meeting date, attendance, legal compliance, and voting results. The content focuses on board/management decisions related to stock incentives, not on financial results, audit opinions, or regulatory filings. The document is relatively short (1096 characters) and is a meeting resolution announcement rather than a full report or presentation. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes or decisions by the company's board or senior management.
2023-09-07 Chinese
监事会关于公司2023年限制性股票激励计划首次授予激励对象名单的核查意见（截至首次授予日）
Regulatory Filings Classification · 90% confidence The document is a supervisory board's verification opinion on the initial grant list of a 2023 restricted stock incentive plan. It references compliance with company law, securities law, stock exchange listing rules, and internal company regulations. The content focuses on the legality and qualifications of the incentive recipients and the approval of the stock grant details. It is not a full financial report, earnings release, or management discussion, nor is it an announcement of voting results or a proxy statement. It is a regulatory compliance and internal governance-related document concerning stock incentives. Given the nature of the content, it fits best under Regulatory Filings (RNS) as it does not match other more specific categories like Share Issue/Capital Change (SHA) because it is a supervisory opinion rather than an announcement of share issuance itself.
2023-09-07 Chinese
安杰思2023 年股权激励首次授予激励对象名单
Capital/Financing Update Classification · 95% confidence The document is a list of stock option incentive plan recipients for the year 2023, detailing the allocation of restricted stock to directors, senior management, and other key personnel. It includes specific numbers of shares granted and percentages relative to the total plan and company stock. This type of document is an announcement related to capital changes, specifically about stock incentives and allocations. It is not a full financial report, earnings release, or management discussion, but rather a capital/financing update regarding stock-based compensation. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is short and focused on stock incentive allocations, fitting the CAP category with high confidence.
2023-09-07 Chinese
安杰思2023年限制性股票激励计划首次授予法律意见书
Capital/Financing Update Classification · 95% confidence The document is a legal opinion issued by a law firm regarding the company's 2023 restricted stock incentive plan's first grant. It details the approval, authorization, grant date, conditions, recipients, price, and quantity of the stock incentive plan. The document references relevant laws and regulations, board and shareholder meetings, and independent opinions. It is not a financial report, earnings release, or regulatory filing but a legal opinion related to a capital incentive plan. This type of document is best classified under Capital/Financing Update (CAP) because it concerns the issuance and terms of a stock incentive plan, which affects the company's capital structure and financing arrangements. The document length (5596 characters) and content confirm it is a substantive legal opinion, not a brief announcement or certification. Therefore, the classification is CAP with high confidence.
2023-09-07 Chinese
安杰思关于召开2023年半年度业绩说明会的公告
Investor Presentation Classification · 95% confidence The document is an announcement about the scheduling and details of a 2023 half-year performance explanation meeting (业绩说明会) for investors. It references the company's 2023 half-year report already published on August 16, 2023, and invites investors to participate in an interactive online session to discuss the half-year results. The document does not contain actual financial statements or substantive financial data but serves as a notice for the upcoming investor presentation event. According to the classification rules, such announcements about meetings or presentations are classified as Investor Presentation (IP) if they focus on financials and strategy, or Report Publication Announcement (RPA) if they announce report availability. However, since this is specifically about an investor meeting to explain half-year results and interact with investors, it fits best as an Investor Presentation (IP) announcement rather than a report publication or regulatory filing. The document length is short and it is clearly an announcement of an event rather than the event content itself or the report. Therefore, the appropriate classification is Investor Presentation (IP).
2023-09-07 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.